S. Galvain

Sublingual‐swallow immunotherapy (SLIT) with a standardized five‐grass‐pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis

A. Pradalier, C. André, A. Claudel, 1999, Allergy.

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

H. Malling, R. Valenta, E. Pastorello, 2008, The Journal of allergy and clinical immunology.

Safety of Sublingual-Swallow Immunotherapy in Children and Adults

C. André, F. Carat, S. Galvain, 2000, International Archives of Allergy and Immunology.

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.

P. Devillier, F. Horak, P. Moingeon, 2009, The Journal of allergy and clinical immunology.

Safety and efficacy studies of liposomes in specific immunotherapy

C. André, S. Galvain, C. Vatrinet, 1999 .

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy

R. Zeldin, F. Horak, P. Moingeon, 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Sublingual‐swallow immunotherapy (SLIT) in patients with asthma due to house‐dust mites: a double‐blind, placebo‐controlled study

D. Caillaud, J. Bousquet, A. Tonnel, 1999, Allergy.

Specific Immunotherapy with Standardized Latex Extract versus Placebo in Latex-Allergic Patients

T. Fuchs, A. Tabar, M. Bilò, 2006, International Archives of Allergy and Immunology.

Changes in basophil activation during grass‐pollen sublingual immunotherapy do not correlate with clinical efficacy

F. Horak, P. Moingeon, R. Zieglmayer, 2011, Allergy.

Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.

H. Malling, R. Valenta, E. Pastorello, 2008, The Journal of allergy and clinical immunology.